At SCOPE Summit, Craig Lipset shared a blunt assessment of clinical trial innovation: the tools exist, regulators are engaged, and digital approaches offer clear quality advantages — yet adoption remains the industry’s biggest hurdle. From evolving FDA inspection expectations to the normalization (and lingering misconceptions) of decentralized trials, Lipset argues progress will depend less on new technology and more on scaling what already works.
- How To Operationalize AI-Enabled eTMF Systems Under The EU AI Act (Part 2)
- How AI-Enabled eTMF Systems Are Impacted By The EU AI Act (Part 1)
- Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
- How Can AI Change Computerized System Validation?
- Digital Tools Are Failing Patients: 3 Ways Clinical Supply Can Protect Data Integrity
- Virtual Reality Endpoints Improve Measurement Of Patients' Real-World Benefit
- Can't-Miss Advice On Selecting Your First AI-Enabled Vendor
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Strengthening eClinical Data Integrity: Data Monitoring
As the use of eCOA expands to incorporate more submission-critical elements, especially key endpoints and factors contributing to protocol analyses, learn how customized compliance strategies are more important than ever to ensure data integrity.
-
Atlantic Research Group Builds Competitive Advantage With Medrio EDC
By using Medrio’s EDC platform, learn how Atlantic Research Group was able to achieve the flexibility needed to span multiple therapeutic areas and eliminate redundancy in documentation.
-
Top Clinical Research Themes And Trends
We analyzed web traffic, content downloads, social media engagement, webinar attendance, and other metrics to determine the themes that caught your attention and aligned with broader industry trends.
-
Lessons From China And The United States On The Use Of RWE In Regulatory Submissions
Read along as authors share their most significant lessons, offering guidance on how to harness the full potential of RWE to drive innovation and efficiency in drug development.
-
Why The Everest Group Named Medable A Leader In eCOA
Discover how this eCOA is leading the charge in accelerating study timelines, boosting patient engagement, and answering real sponsor needs.
-
Open API Provides Better Access, Freedom To Build And Manage Studies
Discover how the integration of all manner of data platforms ranging from central labs to CTMS and beyond can help to overcome interoperability challenges in clinical research.
-
Database To Advance Patient-Focused Drug Development With DHTs
Uncover how the Patient-Focused Digital Measure Report Database resource will leverage patient-reported data to highlight specific indications where DHTs can provide meaningful, patient-centric measures.
-
Mitigating Study Risk With Performance Analytics
Performance metrics for supporting risk-based management can be great, however, this author tells readers why collecting and analyzing data after a study has begun may not be the best approach.
-
The Hidden Cost Of Preferred Vendors
Familiar vendors offer comfort — but at the cost of innovation, fit, and fresh thinking. Ease shouldn’t outweigh excellence when selecting partners for your clinical trial.
-
Paperless Online Remote Source Document Verification
Learn how Clinical Trial Organizations, Monitoring Teams and Clinical Sites can benefit from the way Judi transforms rSDV from a logistical hurdle into a strategic asset.
FROM THE EDITOR
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
- RWE Is Growing Up, And Here's Why That Matters
- The Dream Is EHR-To-EDC — eSource Is The Wake-Up Call
FEATURED PRODUCTS & SERVICES
RECENT NEWSLETTERS
- 02.19.26 -- The Clinical Tools Quietly Reshaping Trial Operations
- 02.12.26 -- How Can AI Change Computerized System Validation?
- 02.05.26 -- Digital Tools Are Failing Patients: Three Ways Clinical Supply Protects Data
- 01.29.26 -- Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders
- 01.22.26 -- The Role Of Open Source In Powering CDISC 360i